Chamath Palihapitiya-backed Clover Health Investments Corp said on Friday it had received a letter from the U.S. Securities and Exchange Commission following a critical report published by noted short-selling specialist Hindenburg Research.
Chamath Palihapitiya-backed Clover Health Investments Corp said on Friday it had received a letter from the U.S. Securities and Exchange Commission following a critical report published by noted short-selling specialist Hindenburg Research.